InvestorWaves

Stories

View all stories
Chart for Data Centers Are Becoming Power Hungry
Data Centers Are Becoming Power Hungry

Data Centers Are Becoming Power Hungry

Chart for IPO Money is Back
IPO Money is Back

IPO Money is Back

Chart for Texas Tapped The Brakes on Data Centers
Texas Tapped The Brakes on Data Centers

Texas Tapped The Brakes on Data Centers

Chart for Business AI Adoption is Still Uneven
Business AI Adoption is Still Uneven

Business AI Adoption is Still Uneven

Chart for The AI Boom Hit The Factory Floor
The AI Boom Hit The Factory Floor

The AI Boom Hit The Factory Floor

Chart for Amazon's AI Buildout Has a Cash Cost
Amazon's AI Buildout Has a Cash Cost

Amazon's AI Buildout Has a Cash Cost

Chart for Korea's Export Boom is an AI Chip Story
Korea's Export Boom is an AI Chip Story

Korea's Export Boom is an AI Chip Story

Chart for Options Trading Keeps Setting Records
Options Trading Keeps Setting Records

Options Trading Keeps Setting Records

Stock Ideas

View all ideas
ROIV

Roivant Sciences Ltd.

Roivant is a technically leading, institutionally held biotech whose stock has outperformed the market while near-term revenue and GAAP EPS remain weak and volatile.

Biotech Therapeutics
A

Agilent Technologies, Inc.

Agilent is a leading laboratory-instrument supplier positioned to benefit from recovering life-science demand after a multi-quarter revenue inflection and very high institutional ownership.

Life Science Tools & CDMO
ZBRA

Zebra Technologies Corp

Zebra Technologies is a leader in data-capture hardware and automation software, with accelerating revenue and GAAP diluted EPS that validate its role in industrial automation growth trends.

Industrial Automation & Robotics
KNSA

Kiniksa Pharmaceuticals International, plc

Kiniksa is a mid-cap therapeutics company showing sustained double-digit quarterly revenue growth, improving GAAP profitability, and strong relative strength versus the S&P 500 as a theme leader.

Biotech Therapeutics
SHC

Sotera Health Co

Sotera Health's steady revenue increases, accelerating GAAP diluted EPS and strong institutional sponsorship, combined with an established uptrend, position it as a timely leader in Life Science Tools & CDMO services.

Life Science Tools & CDMO
PTGX

Protagonist Therapeutics, Inc

Protagonist Therapeutics is a biotech therapeutics leader trading in an established uptrend with strong relative strength, intermittent GAAP profitability, and a recovering revenue run-rate that merits watching.

Biotech Therapeutics

Market insights

View all insights

Market insights, made visual.

Get data-driven insights into stocks and investing themes in a free newsletter that takes 5 minutes to read.

Market insights, made visual.

Get data-driven insights into stocks and investing themes in a free newsletter that takes 5 minutes to read.

Join free. Unsubscribe anytime.